The cell-surface serine protease known as fibroblast activation protein (FAP) affects different hormones and elements of the extracellular matrix. FAP is frequently used as a marker for pro-tumorigenic stroma and is highly upregulated in a variety of cancers.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V86175 | 3BP-3940 | 2803421-14-7 | |
|
V86846 | [99mTc]Tc-6–1 | [99m Tc]Tc-6-1 is a 99mTc-labeled FAPI-46 derivative and a specific fibroblast activation protein (FAP) targeted radiotracer. | |
|
V85878 | AlF-PD-FAPI | ||
|
V118440 | DOTA-2P (FAPI)2 | DOTA-2P(FAPI)2 is a dimeric FAP (fibroblast activating protein) targeting radioactive probe that can be used as a tracer for PET imaging and tumor targeting. | |
|
V119240 | DOTA-ALB-01 | DOTA-ALB-01 is an albumin-bound FAP inhibitor (FAPI) ligand. | |
|
V119214 | DOTA-ALB-02 | DOTA-ALB-02 is an albumin-bound FAP inhibitor (FAPI) ligand. | |
|
V93849 | DOTAGA.(SA.FAPi)2 analogue TFA | DOTAGA.(SA.FAPi)2 analog TFA is an analog of DOTAGA.(SA.FAPi)2 TFA, wherein the ligand and chelator moieties are the same as DOTAGA.(SA.FAPi)2 TFA. | |
|
V94503 | DOTAGA.(SA.FAPi)2 TFA | DOTAGA.(SA.FAPi)2 TFA is a potent inhibitor of dimeric fibroblast activation protein (FAPi). | |
|
V79388 | FAP-IN-1 | 2956858-96-9 | FAP-IN-1 is a fibroblast activation protein (FAP) inhibitor (antagonist) with IC50 of 3.3 nM. |
|
V74897 | FAP-IN-2 | 2471983-20-5 | FAP-IN-2 is an analogue of 99mTc-labeled isonitrile-containing fibroblast activation protein (FAPI) inhibitor that can be used for tumor imaging. |
|
V77022 | FAP-IN-2 TFA | FAP-IN-2 TFA is an analogue of 99mTc-labeled isonitrile-containing FAP inhibitor that can be used for tumor imaging. | |
|
V86845 | FAP-IN-4 | FAP-IN-4 (Comp 10) is a fibroblast activation protein (FAP) inhibitor and a 18F-labeled PET tracer targeting FAP. | |
|
V118521 | FAP-IN-7 | 3020777-28-7 | FAP-IN-7 (compound 5b) is an FAP inhibitor. |
|
V115930 | FAP-IN-8 | 3075119-33-1 | FAP-IN-8 (compound 12i) is a potent PREP and FAP inhibitor with pIC50 values of 8.99 and 10.08 for FAP and PREP, respectively, and IC50 values of 1 nM and 0.08 nM, respectively. |
|
V115247 | FAP6-19 | 3095069-75-0 | FAP6-19 is a radioligand that targets fibroblast activator protein (FAP) with a dissociation constant (Kd) of 18.2 nM. |
|
V74893 | FAPI-2 | 2370952-98-8 | FAPI-2 is a fibroblast activation protein (FAP) inhibitor that has applications in cancer-related research. |
|
V77023 | FAPI-2 TFA | FAPI-2 TFA is a fibroblast activation protein (FAP) inhibitor (antagonist) with potential use in cancer-related research. | |
|
V74894 | FAPI-34 | 2374782-07-5 | FAPI-34 is a fibroblast activating protein (FAP) inhibitor (antagonist) with good pharmacokinetic and biochemical properties, disclosed in patent WO2019154886A1. |
|
V51734 | FAPI-46 | 2374782-04-2 | FAPI-46 is a quinoline-based activator of fibroblast-activated protein (FAP). |
|
V74898 | FAPI-74 | 2374782-76-8 | FAPI-74 is a PET (positron emission tomography) tracer for fibroblast activating protein. |